• Wedbush Reaffirms Neutral Rating for Sage Therapeutics (NASDAQ:SAGE)

    المصدر: Buzz FX / 13 فبراير 2025 10:11:11   America/Chicago


    Wedbush Reaffirms Neutral Rating for Sage Therapeutics (NASDAQ:SAGE) Written by MarketBeat February 13, 2025 Share Link copied to clipboard. Sage Therapeutics ( NASDAQ:SAGE - Get Free Report ) 's stock had its "neutral" rating reaffirmed by
    Read more...
شارك على،